
Phase III ASCENT Study
Author(s) -
Catlin Nalley
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000802752.53360.38
Subject(s) - medicine , vinorelbine , eribulin , gemcitabine , metastatic breast cancer , quality of life (healthcare) , breast cancer , oncology , capecitabine , clinical trial , chemotherapy , cancer , nursing , colorectal cancer , cisplatin